 | Up a level |
2020
Wolf, Juergen, Seto, Takashi, Han, Ji-Youn, Reguart, Noemi, Garon, Edward B., Groen, Harry J. M., Tan, Daniel S. W., Hida, Toyoaki, de Jonge, Maja, Orlov, Sergey V., Smit, Egbert F., Souquet, Pierre-Jean, Vansteenkiste, Johan, Hochmair, Maximilian, Felip, Enriqueta, Nishio, Makoto, Thomas, Michael, Ohashi, Kadoaki, Toyozawa, Ryo, Overbeck, Tobias R., de Marinis, Filippo, Kim, Tae-Min, Laack, Eckart, Robeva, Anna, Le Mouhaer, Sylvie, Waldron-Lynch, Maeve, Sankaran, Banu, Balbin, O. Alejandro, Cui, Xiaoming, Giovannini, Monica, Akimov, Mikhail and Heist, Rebecca S. (2020). Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer. N. Engl. J. Med., 383 (10). S. 944 - 958. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406
2017
Tan, Daniel Shao-Weng, Lee, Dae Ho, Soo, Ross, Michels, Sebastian, Barlesi, Fabrice, Sangha, Randeep, Le Gac, Fabienne, Pultar, Philippe, Glaser, Sabine, Cui, Xiaoming, Akimov, Mikhail and Felipe, Enriqueta (2017). Phase lb Results from a Study of Capmatinib (INC280)+EGF816 in Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC). J. Thorac. Oncol., 12 (1). S. S1264 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380